Literature DB >> 10991860

Animal and human multidrug-resistant, cephalosporin-resistant salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase.

P L Winokur1, A Brueggemann, D L DeSalvo, L Hoffmann, M D Apley, E K Uhlenhopp, M A Pfaller, G V Doern.   

Abstract

Salmonella spp. are important food-borne pathogens that are demonstrating increasing antimicrobial resistance rates in isolates obtained from food animals and humans. In this study, 10 multidrug-resistant, cephalosporin-resistant Salmonella isolates from bovine, porcine, and human sources from a single geographic region were identified. All isolates demonstrated resistance to cephamycins and extended-spectrum cephalosporins as well as tetracycline, chloramphenicol, streptomycin, and sulfisoxazole. Molecular epidemiological analyses revealed eight distinct chromosomal DNA patterns, suggesting that clonal spread could not entirely explain the distribution of this antimicrobial resistance phenotype. However, all isolates encoded an AmpC-like beta-lactamase, CMY-2. Eight isolates contained a large nonconjugative plasmid that could transform Escherichia coli. Transformants coexpressed cephalosporin, tetracycline, chloramphenicol, streptomycin, and sulfisoxazole resistances. Plasmid DNA revealed highly related restriction fragments though plasmids appeared to have undergone some evolution over time. Multidrug-resistant, cephalosporin-resistant Salmonella spp. present significant therapeutic problems in animal and human health care and raise further questions about the association between antimicrobial resistance, antibiotic use in animals, and transfer of multidrug-resistant Salmonella spp. between animals and man.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10991860      PMCID: PMC90151          DOI: 10.1128/AAC.44.10.2777-2783.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  42 in total

1.  Fluoroquinolone resistance in salmonellas and campylobacters from humans.

Authors:  E J Threlfall; J A Frost; B Rowe
Journal:  BMJ       Date:  1999-04-03

2.  Characterisation of CMY-4, an AmpC-type plasmid-mediated beta-lactamase in a Tunisian clinical isolate of Proteus mirabilis.

Authors:  C Verdet; G Arlet; S Ben Redjeb; A Ben Hassen; P H Lagrange; A Philippon
Journal:  FEMS Microbiol Lett       Date:  1998-12-15       Impact factor: 2.742

3.  Emergence of multidrug-resistant Salmonella enterica serotype typhimurium DT104 infections in the United States.

Authors:  M K Glynn; C Bopp; W Dewitt; P Dabney; M Mokhtar; F J Angulo
Journal:  N Engl J Med       Date:  1998-05-07       Impact factor: 91.245

4.  High rates of antimicrobial resistance among clinical isolates of nontyphoidal Salmonella in Taiwan.

Authors:  Y J Yang; C C Liu; S M Wang; J J Wu; A H Huang; C P Cheng
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-12       Impact factor: 3.267

5.  Toward functional genomics in bacteria: analysis of gene expression in Escherichia coli from a bacterial artificial chromosome library of Bacillus cereus.

Authors:  M R Rondon; S J Raffel; R M Goodman; J Handelsman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

6.  Salmonella enteritidis: AmpC plasmid-mediated inducible beta-lactamase (DHA-1) with an ampR gene from Morganella morganii.

Authors:  G Barnaud; G Arlet; C Verdet; O Gaillot; P H Lagrange; A Philippon
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

7.  Molecular characterization of an antibiotic resistance gene cluster of Salmonella typhimurium DT104.

Authors:  C E Briggs; P M Fratamico
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

8.  Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate.

Authors:  P A Bradford; C E Cherubin; V Idemyor; B A Rasmussen; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

9.  Multiple drug resistance patterns and plasmid profiles of non-typhi salmonellae in Turkey.

Authors:  T Yildirmak; A Yazgan; G Ozcengiz
Journal:  Epidemiol Infect       Date:  1998-10       Impact factor: 2.451

10.  Class 1 integron-borne multiple-antibiotic resistance carried by IncFI and IncL/M plasmids in Salmonella enterica serotype typhimurium.

Authors:  F Tosini; P Visca; I Luzzi; A M Dionisi; C Pezzella; A Petrucca; A Carattoli
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

View more
  87 in total

Review 1.  Plasmid-determined AmpC-type beta-lactamases.

Authors:  Alain Philippon; Guillaume Arlet; George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  Characterization of plasmids carrying CMY-2 from expanded-spectrum cephalosporin-resistant Salmonella strains isolated in the United States between 1996 and 1998.

Authors:  A Carattoli; F Tosini; W P Giles; M E Rupp; S H Hinrichs; F J Angulo; T J Barrett; P D Fey
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

3.  Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR.

Authors:  F Javier Pérez-Pérez; Nancy D Hanson
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

4.  International spread of bla(CMY-2)-mediated cephalosporin resistance in a multiresistant Salmonella enterica serovar Heidelberg isolate stemming from the importation of a boar by Denmark from Canada.

Authors:  Frank M Aarestrup; Henrik Hasman; Inger Olsen; Gitte Sørensen
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

5.  Molecular epidemiology of ceftiofur-resistant Escherichia coli isolates from dairy calves.

Authors:  Sarah C Donaldson; Beth A Straley; Narasimha V Hegde; Ashish A Sawant; Chitrita DebRoy; Bhushan M Jayarao
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

6.  Complexity of Klebsiella pneumoniae isolates resistant to both cephamycins and extended-spectrum cephalosporins at a teaching hospital in Taiwan.

Authors:  Jing-Jou Yan; Wen-Chien Ko; Hsiu-Mei Wu; Shu-Huei Tsai; Chin-Luan Chuang; Jiunn-Jong Wu
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

7.  Detection of a bla(SHV) extended-spectrum {beta}-lactamase in Salmonella enterica serovar Newport MDR-AmpC.

Authors:  Shelley C Rankin; Jean M Whichard; Kevin Joyce; Lynn Stephens; Kathleen O'shea; Helen Aceto; Donald S Munro; Charles E Benson
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

8.  VIM-12, a novel plasmid-mediated metallo-beta-lactamase from Klebsiella pneumoniae that resembles a VIM-1/VIM-2 hybrid.

Authors:  Spyros Pournaras; Alexandros Ikonomidis; Leonidas S Tzouvelekis; Despoina Tokatlidou; Nicholas Spanakis; Antonios N Maniatis; Nicholas J Legakis; Athanassios Tsakris
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

9.  AmpC disk test for detection of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal AmpC beta-lactamases.

Authors:  Jennifer A Black; Ellen Smith Moland; Kenneth S Thomson
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

10.  Acquisition of resistance to extended-spectrum cephalosporins by Salmonella enterica subsp. enterica serovar Newport and Escherichia coli in the turkey poult intestinal tract.

Authors:  C Poppe; L C Martin; C L Gyles; R Reid-Smith; P Boerlin; S A McEwen; J F Prescott; K R Forward
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.